,,ii  #aah? ,,congress  #b;d ,session   
,s4 #dgci  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,july #bc1 #bjbd,mr4   
,blum5?al 7= himself1 ,mr4 ,re$1 ,mr4   
,b>rasso1 & ,mr4 ,r\nds7 introduc$ !    
foll[+ bill2 :i* 0 read twice & ref]r$  
to ! ,committee on ,heal?1 ,education1  
,labor1 & ,p5sions  ,a ,,bill  ,to      
advance rese>* to a*ieve m$ical         
break?r\ghs 9 bra9 tumor treatm5t &     
improve aw>5ess & adequacy ( specializ$ 
canc] & bra9 tumor c>e4  #a4 ,%ort      
title2 table ( cont5ts  7a7 ,%ort title 
,?is ,act may be cit$ z ! ,bol/]+       
,rese>* ,& ,innovation ,n[ ,act or !    
,,bra9 ,act4  7b7 ,table ( cont5ts ,!   
table ( cont5ts ( ?is ,act is z foll[s3 
,sec4 #a4 ,%ort title2 table (          
cont5ts4,sec4 #b4 ,f9d+s2 purposes4,sec4
 #c4 ,fo/]+ transp>5cy ( biospecim5     
collections = bra9 canc] rese>*4,sec4   
#d4 ,gliobla/oma ,!rapeutics ,network2  
bra9 tumor ,,c>-,t team sci5ce          
aw>d4,sec4 #e4 ,cl9ical trials & biom>k]
 te/+ national public aw>5ess           

campaign4,sec4 #f4 ,pilot programs to   
develop1 /udy1 or evaluate approa*es to 
monitor+ & c>+ = bra9 tumor             
survivors4,sec4 #g4 ,,fda guidance to   
ensure bra9 tumor pati5t access to      
cl9ical trials4  #b4 ,f9d+s2 purposes   
7a7 ,f9d+s ,congress f9ds z foll[s3 7#a7
 ,accord+ to ! ,national ,bra9 ,tumor   
,society bas$ on data analyz$ 9 #bjbd1 m
 ?an #a1jjj1jjj p 9 ! ,unit$ ,/ates are 
liv+ ) a bra9 tumor & approximately     
#id1jjj 7 e/imat$ to be diagnos$ ) a    
prim>y bra9 tumor 9 #bjbc4  7#b7 ,bra9  
tumors d n discrim9ate & c affect p (   
all races1 g5d]s1 & ages4 ,tragically1  
p$iatric bra9 tumors are ! lead+ cause (
 canc]-relat$ dea? among *ildr5 & "y    
adults ages #ai & y\ng]4  7#c7 ,=       
malignant bra9 tumors1 incid5ce &       
survival rates h rema9$ /agnant = #de   
ye>s1 ) an av]age #e-ye> relative       
survival rate ( #ce4g p]c5t & only #f4i 
p]c5t = gliobla/oma1 ! mo/ common prim>y
 malignant bra9 tumor4  7#d7 ,mo/ prim>y
 bra9 tumors are non-malignant1 b _m    

/ill require surg]y & radiation4 ,!     
results ( available treatm5t options c  
v>y f a successful return to normal life
 to possible disability or a            
life-?reat5+ condition4  7#e7 ,despite !
 /ati/ics describ$ 9 p>agraphs 7#a7     
?r\gh 7#d71 !re h be5 v few treatm5ts   
ev] approv$ by ! ,food & ,drug          
,adm9i/ration to treat bra9 tumors1     
!reby result+ 9 little *ange 9 mortality
 rates = individuals ) bra9 tumors4     
7#f7 ,z ( ! date ( enactm5t ( ?is ,act1 
!re is no prev5tion & no e>ly detection 
protocol = bra9 tumors4  7#g7 ,all p 9 !
 ,unit$ ,/ates h a /ake 9 r$uc+ &       
elim9at+ bra9 tumors4  7#h7 ,pati5ts    
liv+ ) a bra9 tumor & _! families want  
cures4 ,%ort ( cures1 !y want safe &    
effective ways to increase survival     
rates = su* pati5ts & improve ! quality 
( life = su* pati5ts4  7b7 ,purposes ,! 
purposes ( ?is ,act are to-- 7#a7 /r5g!n
 rese>* & treatm5t developm5t reg>d+    
bra9 tumors2 &  7#b7 improve ! adequacy 
& aw>5ess ( & access to specializ$ bra9 

tumor heal? c>e4  #c4 ,fo/]+ transp>5cy 
( biospecim5 collections = bra9 canc]   
rese>* ,"p ,a ( title ,,iv ( ! ,public  
,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bha 
et seq47 is am5d$ by add+ at ! end !    
foll[+3  #djd,p4 ,report+ ( bra9 tumor  
biospecim5 collections  7a7 ,def9ition (
 cov]$ biospecim5 collection  7#a7 ,9   
g5]al ,9 ?is section1 ! t]m cov]$       
biospecim5 collection means a biospecim5
 t 0 collect$ or acquir$ 9 :ole or 9 "p 
?r\gh fund+ f ! ,national ,in/itutes (  
,heal?4  7#b7 ,biospecim5 ,= purposes ( 
p>agraph 7#a71 ! t]m biospecim5 means a 
bra9 tumor tissue1 c]ebral sp9al fluid1 
or o!r specim5 type li/$ by ! ,specim5  
,res\rce ,locator ( ! ,national ,canc]  
,in/itute 7or a successor database74    
7b7 ,e/abli%m5t ,! ,secret>y1 act+ ?r\gh
 ! ,director ( ,,nih1 may e/abli% &     
ma9ta9 a se>*able website1 or multiple  
websites1 :i* may include websites exi/+
 on ! day be=e ! date ( enactm5t ( ?is  
section1 = ! purpose ( mak+ accessible  
to ! public-- 7#a7 in=mation on !       

exi/5ce & location ( cov]$ biospecim5   
collections2  7#b7 a description ( su*  
collections2 &  7#c7 contact in=mation )
 respect to su* collections4  7c7       
,report+ requirem5ts  7#a7 ,exi/+       
collections ,any individual or entity t 
z ( ! date ( enactm5t ( ?is section     
ma9ta9s a cov]$ biospecim5 collection   
%all1 n lat] ?an #ahj days aft] su* date
 ( enactm5t1 submit a report to !       
,director ( ,,nih conta9+ in=mation )   
respect to su* cov]$ biospecim5         
collection z ! ,director ( ,,nih may    
specify1 includ+ at a m9imum ! in=mation
 ! ,national ,canc] ,in/itute requires =
 ! ,specim5 ,res\rce ,locator 7or a     
successor database74  7#b7 ,new         
collections ,any individual or entity t 
collects or acquires a cov]$ biospecim5 
collection on or aft] ! date ( enactm5t 
( ?is section %all1 n lat] ?an #fj days 
aft] ! date ( su* collection or         
acquisition1 submit a report to !       
,director ( ,,nih conta9+ ! in=mation   
requir$ "u p>agraph 7#a74  7d7 ,ov]sight

 ,! ,secret>y1 act+ ?r\gh ! ,director ( 
,,nih1 %all e/abli% & c>ry out an       
ov]sight me*anism1 :i* %all include     
)hold+ fund+ to individuals or entities 
t h committ$ a repeat$ or egregi\s      
violation ( ! requirem5ts "u subsection 
7c74  4  #d4 ,gliobla/oma ,!rapeutics   
,network2 bra9 tumor ,,c>-,t team sci5ce
 aw>d  7a7 ,9 g5]al ,subp>t #a ( "p ,c (
 title ,,iv ( ! ,public ,heal? ,s]vice  
,act 7#db ,u4,s4,c4 #bhe et seq47 is    
am5d$ by add+ at ! end ! foll[+3        
#dag;,h4 ,gliobla/oma ,!rapeutics       
,network  7a7 ,9 g5]al ,! ,director ( ! 
,in/itute %all c>ry out a rese>*        
program1 kn[n z ! ,gliobla/oma          
,!rapeutics ,network1 by aw>d+1 on a    
competitive basis1 coop]ative agreem5ts1
 or o!r aw>ds1 ?r\gh ! ,u#ai fund+      
me*anism ( ! ,national ,in/itutes (     
,heal? = collaboration ( in/itutions to 
improve ! treatm5t ( gliobla/oma by     
evaluat+ !rapeutic ag5ts f pre-cl9ical  
developm5t /udies ?r\gh completion (    
e>ly-phase cl9ical trials 9 humans4  7b7

 ,au?orization ( appropriations ,!re is 
au?oriz$ to be appropriat$ #ej1jjj1jjj =
 ea* ( fiscal ye>s #bjbf ?r\gh #bjcj1 to
 rema9 available until exp5d$1 to !     
,director ( ! ,in/itute to c>ry out ?is 
section4  #dag;,i4 ,bra9 tumor ,,c>-,t  
team sci5ce aw>d  7a7 ,9 g5]al ,9 ord]  
to take advantage ( significant         
advancem5t 9 ! developm5t ( *im]ic      
antig5 receptor-,t 7,,c>-,t7 cell !rapy 
approa*es 9 canc]1 includ+ _m su*       
approa*es previ\sly fund$ by ! ,national
 ,in/itutes ( ,heal?1 ! ,director ( !   
,in/itute %all make aw>ds1 on a         
competitive basis1 ?r\gh a ,u s]ies     
fund+ me*anism1 to support ! developm5t 
( a multi-in/itutional team sci5ce      
approa* to us+ ,,c>-,t treatm5t = adult 
& p$iatric bra9 tumors4  7b7 ,use (     
funds ,funds receiv$ ?r\gh an aw>d "u   
?is section %all be us$-- 7#a7 to       
support collaborative multi-in/itutional
 rese>* activities1 includ+ pre-cl9ical 
& inve/igational new drug /udies2 &     
7#b7 = ! purpose ( support+ cl9ical     

trials to evaluate ,,c>-,t !rapeutic    
approa*es to treat+ bra9 tumors4  7c7   
,au?orization ( appropriations ,!re is  
au?oriz$ to be appropriat$ #aj1jjj1jjj =
 ea* ( fiscal ye>s #bjbf ?r\gh #bjcj1 to
 rema9 available until exp5d$1 to !     
,director ( ! ,in/itute to c>ry out ?is 
section4  4  7b7 ,transition = !        
,gliobla/oma ,!rapeutics ,network ,!    
,director ( ! ,national ,canc] ,in/itute
 %all take su* /eps z may be necess>y = 
! ord]ly transition f ! ,gliobla/oma    
,!rapeutics ,network c>ri$ out by !     
,director1 z ( ! day be=e ! date (      
enactm5t ( ?is ,act1 to ! rese>* program
 au?oriz$ "u section #dag;,h ( ! ,public
 ,heal? ,s]vice ,act1 z add$ by         
subsection 7a74 ,9 mak+ su* transition1 
! ,director %all ensure t ! program     
au?oriz$ "u su* section #dag;,h is bas$ 
^u & consi/5t ) ! policies & proc$ures (
 ! ,gliobla/oma ,!rapeutics ,network    
c>ri$ out by ! ,director z ( ! day be=e 
! date ( enactm5t ( ?is ,act4  #e4      
,cl9ical trials & biom>k] te/+ national 

public aw>5ess campaign ,"p ,p ( title  
,,iii ( ! ,public ,heal? ,s]vice ,act   
7#db ,u4,s4,c4 #bhj;g et seq47 is am5d$ 
by add+ at ! end ! foll[+3  #cii,v-#h4  
,cl9ical trials & biom>k] te/+ national 
public aw>5ess campaign  7a7 ,national  
campaign  7#a7 ,9 g5]al ,! ,secret>y    
%all c>ry out a national campaign to    
increase ! aw>5ess & k ( heal? c>e      
provid]s & individuals ) respect to !   
importance ( cl9ical trials 9 ! treatm5t
 ( canc]4  7#b7 ,activities  7,a7 ,9    
g5]al ,activities "u su* national       
campaign %all include ea* ( ! foll[+3   
7i7 ,writt5 mat]ials ,ma9ta9+ a supply (
 writt5 & digital mat]ials t provide    
in=mation to ! public on cl9ical trials1
 & di/ribut+ su* mat]ials to memb]s ( ! 
public ^u reque/4  7ii7 ,public s]vice  
ann\ncem5ts2 public engagem5t ,provid+  
public s]vice ann\ncem5ts1 9 accordance 
) applicable law1 includ+ ?r\gh publi%+ 
mat]ials 9 digital or pr9t =m1 & c>ry+  
out o!r public engagem5t initiatives4   
,su* public s]vice ann\ncem5ts & o!r    

public engagem5t initiatives %all       
include su* ann\ncem5ts & initiatives   
int5d$ to enc\rage individuals to       
discuss ) _! physicians-- 7,i7 :at      
cl9ical trials are2  7,,ii7 ! importance
 ( cl9ical trials 9 ! treatm5t ( canc]2 
7,,iii7 h[ to enroll 9 cl9ical trials2  
7,,iv7 :at biom>k] te/+ is2  7,v7 !     
importance ( biom>k] te/+ 9 ! treatm5t (
 canc]2 &  7,,vi7 h[ to access biom>k]  
te/+4  7,b7 ,t>get$ populations ,!      
,secret>y %all ensure t ! national      
campaign includes communications1       
includ+ public s]vice ann\ncem5ts & o!r 
public engagem5t initiatives "u         
subp>agraph 7,a77ii71 t are-- 7i7       
culturally & l+ui/ically compet5t2 &    
7ii7 t>get$ to-- 7,i7 specific          
populations t are at a high] risk (     
canc]1 includ+ su* populations bas$ on  
factors includ+ race1 e?nicity1 level ( 
acculturation1 & family hi/ory2  7,,ii7 
rural communities2 &  7,,iii7 su* o!r   
communities z ! ,secret>y det]m9es      
appropriate4  7#c7 ,consultation ,9     

c>ry+ out ! national campaign "u ?is    
subsection1 ! ,secret>y %all consult )--
 7,a7 heal? c>e provid]s2  7,b7 nonpr(it
 organizations2  7,c7 ,/ate & local     
public heal? dep>tm5ts2 &  7,d7 elem5t>y
 & second>y s*ools & in/itutions ( high]
 education4  7b7 ,demon/ration projects 
reg>d+ outrea* & education /rategies =  
canc] & bra9 tumor pati5ts  7#a7 ,9     
g5]al ,! ,secret>y %all c>ry out a      
program to aw>d grants or contracts to  
public or nonpr(it private entities = ! 
purpose ( c>ry+ out demon/ration        
projects to te/1 comp>e1 & evaluate     
diff]5t evid5ce-bas$ outrea* & education
 /rategies to increase ! aw>5ess & k (  
canc]1 includ+ bra9 tumor biom>k] te/+ &
 bra9 tumor cl9ical trials4 ,su*        
projects %all focus on ! aw>5ess & k (  
pati5ts 7& ! families ( pati5ts71       
physicians1 nurses1 & o!r key heal?     
pr(essionals involv$ 9 bra9 tumor       
treatm5t4  7#b7 ,aw>ds ,9 mak+ aw>ds "u 
p>agraph 7#a71 ! ,secret>y %all-- 7,a7  
ensure t in=mation provid$ ?r\gh        

demon/ration projects support$ by su* an
 aw>d is consi/5t ) ! be/ available     
m$ical in=mation2 &  7,b7 give pref]5ce 
to-- 7i7 applicants ) demon/rat$        
exp]tise 9-- 7,i7 biom>k] te/+ & cl9ical
 trials 9 bra9 tumors & o!r recalcitrant
 canc]s2  7,,ii7 bra9 canc] & o!r       
recalcitrant canc] education or         
treatm5t2  7,,iii7 work+ ) gr\ps (      
pati5ts & c>egiv]s2 &  7,,iv7 rea*+     
geographic areas t h hi/orically l[     
rates ( p>ticipation 9 canc] cl9ical    
trials2 &  7ii7 applicants t demon/rate 
9 _! application submitt$ "u p>agraph   
7#c7 t ! project = :i* !y are seek+ a   
grant or contract w involve & connect   
physicians1 nurses1 o!r key heal?       
pr(essionals1 heal? pr(ession /ud5ts1   
hospitals1 & pay]s4  7#c7 ,applications 
,to seek a grant or contract "u ?is     
subsection1 an entity %all submit an    
application to ! ,secret>y 9 su* =m1 9  
su* mann]1 & conta9+ su* agreem5ts1     
assurances1 & in=mation z ! ,secret>y   
may reasonably require4  7c7            

,au?orization ( appropriations ,= !     
purpose ( c>ry+ out ?is section1 !re is 
au?oriz$ to be appropriat$ #aj1jjj1jjj =
 ! p]iod ( fiscal ye>s #bjbf ?r\gh      
#bjcj4  4  #f4 ,pilot programs to       
develop1 /udy1 or evaluate approa*es to 
monitor+ & c>+ = bra9 tumor survivors   
,"p ,b ( title ,,iv ( ! ,public ,heal?  
,s]vice ,act 7#db ,u4,s4,c4 #bhd et     
seq47 is am5d$ by add+ at ! end !       
foll[+3  #dji,k4 ,pilot programs to     
develop1 /udy1 or evaluate approa*es to 
monitor+ & c>+ = bra9 tumor survivors   
7a7 ,9 g5]al ,! ,director ( ,,nih may1 z
 appropriate1 make aw>ds to eligible    
entities to e/abli% pilot programs to   
develop1 /udy1 or evaluate approa*es1   
includ+ prim>y c>e1 = monitor+ & c>+ =  
adult & p$iatric bra9 tumor survivors   
?r\gh\t _! lifespan1 includ+ evaluat+   
models = transition to po/-treatm5t c>e 
& c>e coord9ation4  7b7 ,aw>ds  7#a7    
,eligible entities  7,a7 ,9 g5]al ,=    
purposes ( ?is section1 an eligible     
entity is-- 7i7 a m$ical s*ool2  7ii7 a 

*ildr5's hospital2  7iii7 a canc] c5t]2 
7iv7 a community-bas$ m$ical facility2  
or  7v7 any o!r entity ) significant    
exp]i5ce & exp]tise 9 c>ry+ out !       
activities describ$ 9 subsection 7a74   
7,b7 ,types ( entities ,aw>ds "u ?is    
section %all be made1 to ! ext5t        
practical1 to-- 7i7 small1 m$ium1 &     
l>ge-siz$ eligible entities2 &  7ii7    
sites locat$ 9 diff]5t geographic areas1
 includ+ rural & urban areas4  7#b7 ,pe]
 review ,9 mak+ aw>ds "u ?is section1 ! 
,director ( ,,nih %all comply ) ! pe]   
review requirem5ts 9 section #dib4  7#c7
 ,use ( funds ,funds f aw>ds "u ?is     
section may be us$ to develop1 /udy1 or 
evaluate "o or m models = monitor+ & c>+
 = bra9 tumor survivors1 :i* may        
include-- 7,a7 evaluat+ foll[-up c>e1   
educational accommodations1 monitor+1 & 
o!r survivor%ip programs 7includ+ pe]   
support & m5tor+ programs72  7,b7       
develop+ & evaluat+ models = provid+    
multidiscipl9>y c>e2  7,c7 dissem9at+   
in=mation to heal? c>e provid]s ab\t    

culturally & l+ui/ically appropriate    
foll[-up c>e = bra9 tumor survivors & _!
 families1 z appropriate & practicable2 
7,d7 develop+ & evaluat+ exi/+          
psy*osocial evaluations1 c\nsel+1 &     
support programs to improve ! quality ( 
life ( bra9 tumor survivors & _!        
families1 :i* may include pe] support & 
m5tor+ programs2  7,e7 design+ &        
evaluat+ tools to support ! secure      
electronic transf] ( treatm5t in=mation 
& c>e summ>ies f bra9 tumor c>e provid]s
 to o!r heal? c>e provid]s 7includ+     
prim>y c>e provid]s71 :i* in=mation &   
c>e summ>ies %all include risk factors &
 a plan = recomm5d$ foll[-up c>e2  7,f7 
develop+ & evaluat+ initiatives t       
promote ! coord9ation & effective       
transition ( c>e betwe5 bra9 tumor c>e  
provid]s1 prim>y c>e provid]s1 m5tal    
heal? pr(essionals1 & o!r heal? c>e     
pr(essionals1 z appropriate1 includ+    
models t use a team-bas$ or             
multi-discipl9>y approa* to c>e2 &  7,g7
 dissem9at+ in=mation describ$ 9        

subp>agraphs 7,a7 ?r\gh 7,f71 includ+ ) 
respect to models1 evaluations1         
programs1 sy/ems1 & initiatives describ$
 9 su* subp>agraphs1 to o!r heal? c>e   
provid]s 7includ+ prim>y c>e provid]s7 &
 to p$iatric bra9 tumor survivors & _!  
families1 :]e appropriate & 9 accordance
 ) ,f$]al & ,/ate law4  7c7             
,au?orization ( appropriations ,!re are 
au?oriz$ to be appropriat$ to c>ry out  
?is section #e1jjj1jjj = ea* ( fiscal   
ye>s #bjbf ?r\gh #bjcj4  4  #g4 ,,fda   
guidance to ensure bra9 tumor pati5t    
access to cl9ical trials ,n lat] ?an #a 
ye> aft] ! date ( enactm5t ( ?is ,act1 !
 ,secret>y ( ,heal? & ,human ,s]vices1  
act+ ?r\gh ! ,commission] ( ,food &     
,drugs1 %all issue guidance to help     
id5tify ways to m9imize ! pot5tial = !  
exclusion ( bra9 tumor pati5ts & pati5ts
 ) r>e & recalcitrant canc]s f cl9ical  
trials evaluat+ treatm5ts = o!r         
indications4